<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32265469</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca<sup>2+</sup> signaling and dysregulated cell metabolism.</ArticleTitle><Pagination><StartPage>6003</StartPage><MedlinePgn>6003</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6003</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-62864-5</ELocationID><Abstract><AbstractText>Most cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have cytoplasmic inclusions of TAR DNA-binding protein 43 (TDP-43) in neurons and non-neuronal cells, including astrocytes, which metabolically support neurons with nutrients. Neuronal metabolism largely depends on the activation of the noradrenergic system releasing noradrenaline. Activation of astroglial adrenergic receptors with noradrenaline triggers cAMP and Ca<sup>2+</sup> signaling and augments aerobic glycolysis with production of lactate, an important neuronal energy fuel. Astrocytes with cytoplasmic TDP-43 inclusions can cause motor neuron death, however, whether astroglial metabolism and metabolic support of neurons is altered in astrocytes with TDP-43 inclusions, is unclear. We measured lipid droplet and glucose metabolisms in astrocytes expressing the inclusion-forming C-terminal fragment of TDP-43 or the wild-type TDP-43 using fluorescent dyes or genetically encoded nanosensors. Astrocytes with TDP-43 inclusions exhibited a 3-fold increase in the accumulation of lipid droplets versus astrocytes expressing wild-type TDP-43, indicating altered lipid droplet metabolism. In these cells the noradrenaline-triggered increases in intracellular cAMP and Ca<sup>2+</sup> levels were reduced by 35% and 31%, respectively, likely due to the downregulation of &#x3b2;<sub>2</sub>-adrenergic receptors. Although noradrenaline triggered a similar increase in intracellular lactate levels in astrocytes with and without TDP-43 inclusions, the probability of activating aerobic glycolysis was facilitated by 1.6-fold in astrocytes with TDP-43 inclusions and lactate MCT1 transporters were downregulated. Thus, while in astrocytes with TDP-43 inclusions noradrenergic signaling is reduced, aerobic glycolysis and lipid droplet accumulation are facilitated, suggesting dysregulated astroglial metabolism and metabolic support of neurons in TDP-43-associated ALS and FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Velebit</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Engineering, Celica Biomedical, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Horvat</LastName><ForeName>Anemari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Engineering, Celica Biomedical, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neuroendocrinology - Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smoli&#x10d;</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrinology - Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prpar Mihevc</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogelj</LastName><ForeName>Boris</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3898-1943</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute BRIS, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Chemistry and Chemical Technology, University of Ljubljana, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorec</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7478-3875</Identifier><AffiliationInfo><Affiliation>Laboratory of Cell Engineering, Celica Biomedical, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neuroendocrinology - Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardjan</LastName><ForeName>Nina</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8174-1668</Identifier><AffiliationInfo><Affiliation>Laboratory of Cell Engineering, Celica Biomedical, 1000, Ljubljana, Slovenia. nina.vardjan@mf.uni-lj.si.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neuroendocrinology - Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia. nina.vardjan@mf.uni-lj.si.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011941">Receptors, Adrenergic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000627100">Tardbp protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>E0399OZS9N</RegistryNumber><NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011941" MajorTopicYN="N">Receptors, Adrenergic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32265469</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-62864-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, et al. Amyotrophic lateral sclerosis. Nature reviews. Disease primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Invest. 2015;125:1767&#x2013;1779. doi: 10.1172/jci71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2011;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Radford RA, et al. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front. Cell. Neurosci. 2015;9:414. doi: 10.3389/fncel.2015.00414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00414</ArticleId><ArticleId IdType="pmc">PMC4621294</ArticleId><ArticleId IdType="pubmed">26578880</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan SA, Barres BA. Glia as primary drivers of neuropathology in TDP-43 proteinopathies. Proc. Natl. Acad. Sci. USA. 2013;110:4439&#x2013;4440. doi: 10.1073/pnas.1301608110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301608110</ArticleId><ArticleId IdType="pmc">PMC3607032</ArticleId><ArticleId IdType="pubmed">23471990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010;6:211&#x2013;220. doi: 10.1038/nrneurol.2010.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.18</ArticleId><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, et al. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Sidle KC, Hardy J. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS) Neuropathol. Appl. Neurobiol. 2015;41:578&#x2013;597. doi: 10.1111/nan.12206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain. 2010;133:1763&#x2013;1771. doi: 10.1093/brain/awq111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq111</ArticleId><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>Prpar Mihevc S, et al. Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Brain. 2017;140:13&#x2013;26. doi: 10.1093/brain/aww197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww197</ArticleId><ArticleId IdType="pubmed">27497493</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;talekar M, et al. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience. 2015;293:157&#x2013;170. doi: 10.1016/j.neuroscience.2015.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.046</ArticleId><ArticleId IdType="pubmed">25743254</ArticleId></ArticleIdList></Reference><Reference><Citation>Prpar Mihevc S, Baralle M, Buratti E, Rogelj B. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci Rep. 2016;6:33996. doi: 10.1038/srep33996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33996</ArticleId><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin Ther Targets. 2018;22:279&#x2013;293. doi: 10.1080/14728222.2018.1439923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci. 2014;127:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. J. Biol. Chem. 2009;284:8516&#x2013;8524. doi: 10.1074/jbc.M809462200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809462200</ArticleId><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, et al. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell. Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberheim NA, Goldman SA, Nedergaard M. Heterogeneity of astrocytic form and function. Methods Mol Biol. 2012;814:23&#x2013;45. doi: 10.1007/978-1-61779-452-0_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-452-0_3</ArticleId><ArticleId IdType="pmc">PMC3506190</ArticleId><ArticleId IdType="pubmed">22144298</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A, Nedergaard M. Physiology of Astroglia. Physiol. Rev. 2018;98:239&#x2013;389. doi: 10.1152/physrev.00042.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00042.2016</ArticleId><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros LF. Metabolic signaling by lactate in the brain. Trends Neurosci. 2013;36:396&#x2013;404. doi: 10.1016/j.tins.2013.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.04.002</ArticleId><ArticleId IdType="pubmed">23639382</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller MS, Fouyssac M, Taylor CW. Effective Glucose Uptake by Human Astrocytes Requires Its Sequestration in the Endoplasmic Reticulum by Glucose-6-Phosphatase-&#x3b2;. Curr Biol. 2018;28:3481&#x2013;3486.e3484. doi: 10.1016/j.cub.2018.08.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.08.060</ArticleId><ArticleId IdType="pmc">PMC6224479</ArticleId><ArticleId IdType="pubmed">30415704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding F, et al. &#x3b1;1-Adrenergic receptors mediate coordinated Ca2+ signaling of cortical astrocytes in awake, behaving mice. Cell Calcium. 2013;54:387&#x2013;394. doi: 10.1016/j.ceca.2013.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2013.09.001</ArticleId><ArticleId IdType="pmc">PMC3858490</ArticleId><ArticleId IdType="pubmed">24138901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekar LK, He W, Nedergaard M. Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. Cereb Cortex. 2008;18:2789&#x2013;2795. doi: 10.1093/cercor/bhn040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhn040</ArticleId><ArticleId IdType="pmc">PMC2583159</ArticleId><ArticleId IdType="pubmed">18372288</ArticleId></ArticleIdList></Reference><Reference><Citation>Paukert M, et al. Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron. 2014;82:1263&#x2013;1270. doi: 10.1016/j.neuron.2014.04.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.04.038</ArticleId><ArticleId IdType="pmc">PMC4080721</ArticleId><ArticleId IdType="pubmed">24945771</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienel GA, Cruz NF. Aerobic glycolysis during brain activation: adrenergic regulation and influence of norepinephrine on astrocytic metabolism. J Neurochem. 2016;138:14&#x2013;52. doi: 10.1111/jnc.13630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13630</ArticleId><ArticleId IdType="pubmed">27166428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorec, R., Parpura, V. &amp; Verkhratsky, A. Preventing neurodegeneration by adrenergic astroglial excitation. FEBS J, 10.1111/febs.14456 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29630772</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz L, Lovatt D, Goldman SA, Nedergaard M. Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i. Neurochem. Int. 2010;57:411&#x2013;420. doi: 10.1016/j.neuint.2010.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2010.03.019</ArticleId><ArticleId IdType="pmc">PMC2934885</ArticleId><ArticleId IdType="pubmed">20380860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz L, Chen Y, Gibbs ME, Zang P, Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders? Curr. Drug Targets CNS Neurol. Disord. 2004;3:239&#x2013;267. doi: 10.2174/1568007043337535.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568007043337535</ArticleId><ArticleId IdType="pubmed">15180484</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki C. Beta-adrenergic receptors: astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry. J Neurosci. 1992;12:781&#x2013;792. doi: 10.1523/JNEUROSCI.12-03-00781.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.12-03-00781.1992</ArticleId><ArticleId IdType="pmc">PMC2838201</ArticleId><ArticleId IdType="pubmed">1347560</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardjan, N. &amp; Zorec, R. Excitable Astrocytes: Ca(2+)- and cAMP-Regulated Exocytosis. Neurochem. Res., 10.1007/s11064-015-1545-x (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25732760</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardjan N, Kreft M, Zorec R. Dynamics of &#x3b2;-adrenergic/cAMP signaling and morphological changes in cultured astrocytes. Glia. 2014;62:566&#x2013;579. doi: 10.1002/glia.22626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22626</ArticleId><ArticleId IdType="pubmed">24464905</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvat, A. &amp; Vardjan, N. Astroglial cAMP signalling in space and time. Neurosci Lett, 10.1016/j.neulet.2018.06.025 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29908259</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvat A, Zorec R, Vardjan N. Adrenergic stimulation of single rat astrocytes results in distinct temporal changes in intracellular Ca(2+) and cAMP-dependent PKA responses. Cell Calcium. 2016;59:156&#x2013;163. doi: 10.1016/j.ceca.2016.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2016.01.002</ArticleId><ArticleId IdType="pubmed">26794933</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell J, Zeppenfeld D, McConnell E, Pena S, Nedergaard M. Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem. Res. 2012;37:2496&#x2013;2512. doi: 10.1007/s11064-012-0818-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-012-0818-x</ArticleId><ArticleId IdType="pmc">PMC3548657</ArticleId><ArticleId IdType="pubmed">22717696</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86:883&#x2013;901. doi: 10.1016/j.neuron.2015.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.035</ArticleId><ArticleId IdType="pubmed">25996133</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19:235&#x2013;249. doi: 10.1038/nrn.2018.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2018.19</ArticleId><ArticleId IdType="pubmed">29515192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, et al. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:2627&#x2013;2641. doi: 10.1093/brain/awr193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P, et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008;28:4115&#x2013;4122. doi: 10.1523/JNEUROSCI.5308-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5308-07.2008</ArticleId><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B, et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65:592&#x2013;605. doi: 10.1002/glia.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160:177&#x2013;190. doi: 10.1016/j.cell.2014.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.12.019</ArticleId><ArticleId IdType="pmc">PMC4377295</ArticleId><ArticleId IdType="pubmed">25594180</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, MacKenzie KR, Putluri N, Maletic-Savatic M, Bellen HJ. The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. Cell Metab. 2017;26:719&#x2013;737.e716. doi: 10.1016/j.cmet.2017.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.08.024</ArticleId><ArticleId IdType="pmc">PMC5677551</ArticleId><ArticleId IdType="pubmed">28965825</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB, et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci Rep. 2019;9:11642. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kis V, Barti B, Lippai M, Sass M. Specialized Cortex Glial Cells Accumulate Lipid Droplets in Drosophila melanogaster. PLoS One. 2015;10:e0131250. doi: 10.1371/journal.pone.0131250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131250</ArticleId><ArticleId IdType="pmc">PMC4493057</ArticleId><ArticleId IdType="pubmed">26148013</ArticleId></ArticleIdList></Reference><Reference><Citation>Henne, W. M., Reese, M. L. &amp; Goodman, J. M. The assembly of lipid droplets and their roles in challenged cells. EMBO J37, 10.15252/embj.201898947 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003646</ArticleId><ArticleId IdType="pubmed">29789390</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiam AR, Farese RV, Walther TC. The biophysics and cell biology of lipid droplets. Nat Rev Mol Cell Biol. 2013;14:775&#x2013;786. doi: 10.1038/nrm3699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3699</ArticleId><ArticleId IdType="pmc">PMC4526153</ArticleId><ArticleId IdType="pubmed">24220094</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K. &amp; Van Den Bosch, L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaev VO, B&#xfc;nemann M, Hein L, Hannawacker A, Lohse MJ. Novel single chain cAMP sensors for receptor-induced signal propagation. The Journal of Biological Chemistry. 2004;279:37215&#x2013;37218. doi: 10.1074/jbc.C400302200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C400302200</ArticleId><ArticleId IdType="pubmed">15231839</ArticleId></ArticleIdList></Reference><Reference><Citation>San Martin A, et al. A genetically encoded FRET lactate sensor and its use to detect the Warburg effect in single cancer cells. PLoS One. 2013;8:e57712. doi: 10.1371/journal.pone.0057712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057712</ArticleId><ArticleId IdType="pmc">PMC3582500</ArticleId><ArticleId IdType="pubmed">23469056</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 2008;65:636&#x2013;641. doi: 10.1001/archneur.65.5.636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.636</ArticleId><ArticleId IdType="pubmed">18474740</ArticleId></ArticleIdList></Reference><Reference><Citation>Salm AK, McCarthy KD. Norepinephrine-evoked calcium transients in cultured cerebral type 1 astroglia. Glia. 1990;3:529&#x2013;538. doi: 10.1002/glia.440030612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440030612</ArticleId><ArticleId IdType="pubmed">2148555</ArticleId></ArticleIdList></Reference><Reference><Citation>De Keyser J, Wilczak N, Leta R, Streetland C. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology. 1999;53:1628&#x2013;1633. doi: 10.1212/WNL.53.8.1628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.8.1628</ArticleId><ArticleId IdType="pubmed">10563603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JT, et al. Roles of beta-adrenergic receptors in Alzheimer&#x2019;s disease: implications for novel therapeutics. Brain Res. Bull. 2011;84:111&#x2013;117. doi: 10.1016/j.brainresbull.2010.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2010.11.004</ArticleId><ArticleId IdType="pubmed">21129453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Yuen EY, Zhou Y, Yan Z, Xiang YK. Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons. J. Biol. Chem. 2011;286:31852&#x2013;31863. doi: 10.1074/jbc.M111.244335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.244335</ArticleId><ArticleId IdType="pmc">PMC3173113</ArticleId><ArticleId IdType="pubmed">21757762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita M, et al. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Mol Psychiatry. 2017;22:754&#x2013;759. doi: 10.1038/mp.2016.171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.171</ArticleId><ArticleId IdType="pmc">PMC5388600</ArticleId><ArticleId IdType="pubmed">27725657</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs ME, Hutchinson DS, Summers RJ. Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for &#x3b1;- and &#x3b2;-adrenergic receptors. Neuroscience. 2010;170:1209&#x2013;1222. doi: 10.1016/j.neuroscience.2010.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.07.052</ArticleId><ArticleId IdType="pubmed">20709158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz L, et al. Brain glycogenolysis, adrenoceptors, pyruvate carboxylase, Na(+), K(+)-ATPase and Marie E. Gibbs&#x2019; pioneering learning studies. Front. Integr. Neurosci. 2013;7:1&#x2013;7. doi: 10.3389/fnint.2013.00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnint.2013.00020</ArticleId><ArticleId IdType="pmc">PMC3615183</ArticleId><ArticleId IdType="pubmed">23565080</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson BN, Minneman KP. Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial cultures. J. Neurochem. 1991;56:587&#x2013;595. doi: 10.1111/j.1471-4159.1991.tb08190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1991.tb08190.x</ArticleId><ArticleId IdType="pubmed">1671087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2009;106:7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg SA, Watts GD, Kimonis VE, Amato AA, Pinkus JL. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis. Muscle Nerve. 2007;36:447&#x2013;454. doi: 10.1002/mus.20823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20823</ArticleId><ArticleId IdType="pubmed">17626287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekny M, et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol. 2016;131:323&#x2013;345. doi: 10.1007/s00401-015-1513-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1513-1</ArticleId><ArticleId IdType="pubmed">26671410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi F, et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. USA. 2013;110:4069&#x2013;4074. doi: 10.1073/pnas.1218497110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218497110</ArticleId><ArticleId IdType="pmc">PMC3593910</ArticleId><ArticleId IdType="pubmed">23431168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, et al. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 2009;29:234&#x2013;249. doi: 10.1523/jneurosci.5273-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.5273-08.2009</ArticleId><ArticleId IdType="pmc">PMC6664907</ArticleId><ArticleId IdType="pubmed">19129400</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, Bonvento G. Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 2008;38:231&#x2013;241. doi: 10.1007/s12035-008-8043-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-008-8043-y</ArticleId><ArticleId IdType="pubmed">18931960</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Riani M, et al. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation. Cell Tissue Res. 2017;370:391&#x2013;401. doi: 10.1007/s00441-017-2681-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2681-1</ArticleId><ArticleId IdType="pubmed">28864831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou MS, et al. Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell. 2019;177:1522&#x2013;1535.e1514. doi: 10.1016/j.cell.2019.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.001</ArticleId><ArticleId IdType="pubmed">31130380</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Barres BA. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/j.immuni.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza PT, Viola JP. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent. Fatty Acids. 2010;82:243&#x2013;250. doi: 10.1016/j.plefa.2010.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2010.02.005</ArticleId><ArticleId IdType="pubmed">20206487</ArticleId></ArticleIdList></Reference><Reference><Citation>Laureys G, et al. Astrocytic beta(2)-adrenergic receptors: from physiology to pathology. Prog Neurobiol. 2010;91:189&#x2013;199. doi: 10.1016/j.pneurobio.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.01.011</ArticleId><ArticleId IdType="pubmed">20138112</ArticleId></ArticleIdList></Reference><Reference><Citation>De Keyser J, Zeinstra E, Wilczak N. Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol. Dis. 2004;15:331&#x2013;339. doi: 10.1016/j.nbd.2003.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.10.012</ArticleId><ArticleId IdType="pubmed">15006703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA. 1994;91:10625&#x2013;10629. doi: 10.1073/pnas.91.22.10625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.22.10625</ArticleId><ArticleId IdType="pmc">PMC45074</ArticleId><ArticleId IdType="pubmed">7938003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J, Wilson D. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia. 1992;5:75&#x2013;80. doi: 10.1002/glia.440050111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440050111</ArticleId><ArticleId IdType="pubmed">1531812</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardjan N, et al. Adrenergic activation attenuates astrocyte swelling induced by hypotonicity and neurotrauma. Glia. 2016;64:1034&#x2013;1049. doi: 10.1002/glia.22981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22981</ArticleId><ArticleId IdType="pmc">PMC4841273</ArticleId><ArticleId IdType="pubmed">27018061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreft M, Milisav I, Potokar M, Zorec R. Automated high through-put colocalization analysis of multichannel confocal images. Comput Methods Programs Biomed. 2004;74:63&#x2013;67. doi: 10.1016/S0169-2607(03)00071-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-2607(03)00071-3</ArticleId><ArticleId IdType="pubmed">14992827</ArticleId></ArticleIdList></Reference><Reference><Citation>Prebil M, Vardjan N, Jensen J, Zorec R, Kreft M. Dynamic monitoring of cytosolic glucose in single astrocytes. Glia. 2011;59:903&#x2013;913. doi: 10.1002/glia.21161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21161</ArticleId><ArticleId IdType="pubmed">21381116</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardjan N, et al. Enhancement of Astroglial Aerobic Glycolysis by Extracellular Lactate-Mediated Increase in cAMP. Front Mol Neurosci. 2018;11:148. doi: 10.3389/fnmol.2018.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00148</ArticleId><ArticleId IdType="pmc">PMC5953330</ArticleId><ArticleId IdType="pubmed">29867342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>